Dupilumab for Post-Hematopoietic Cell Transplantation Dermatitis in Wiskott-Aldrich Syndrome

J Clin Immunol. 2023 Oct;43(7):1526-1528. doi: 10.1007/s10875-023-01525-4. Epub 2023 May 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Dermatitis*
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Wiskott-Aldrich Syndrome Protein
  • Wiskott-Aldrich Syndrome* / therapy

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized
  • Wiskott-Aldrich Syndrome Protein